Rate My Professor Nadine Ezard

Professor Ezard's research centers on substance use disorders, with a focus on stimulants like methamphetamine, emerging drugs of concern, and harm-reduction interventions tailored to vulnerable populations such as refugees and displaced persons. She is recognized worldwide for translating research into public health policy, models of care, and consumer-focused interventions. She has produced extensive scholarly output, including over 120 journal articles, books, chapters, and reports. Key publications encompass "Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic" (2020, Harm Reduction Journal), "Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review" (2020, CNS Drugs), "Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study" (2017, The Lancet Gastroenterology & Hepatology), and "Six rapid assessments of alcohol and other substance use in populations displaced by conflict" (2011, Conflict and Health). Awards include the Australian Financial Review 100 Women of Influence (2016), Commonwealth Scholarships (2007-2011 and 2008), and Harkness Fellowship (1997-1998).